Ray Forslund

Dr. Forslund received his Ph.D. in Organic Chemistry from the University of Illinois at Chicago and his MBA from Babson College. Ray has 20 years of experience in the pharmaceutical industry working for both pharmaceutical and CRO/CMO companies. In his current role as Senior Vice President at Syner-G BioPharma Group, Ray leads the CMC Development, Project Management, and Quality Assurance business units. His combination of scientific and business knowledge allow him to deliver advice and solutions that not only work as a technical matter, but make sense for his client’s business. Specifically, Ray’s team at Syner-G BioPharma Group is made of a diverse group of scientists who follow his lead in providing practical scientific solutions for drug development programs including identifying and managing CRO/CMO/CDMOs for clients to support drug substance, drug product and analytical development activities in biologics, small molecules and peptides. Ray’s scientific team is also tasked with providing CMC strategy and Program Management oversight of development and clinical stage programs, while also leveraging Syner-G’s regulatory specialists as needed. Previously, Ray was part of the Senior Leadership team at Laurus Synthesis Inc. (LSI), a Boston based CRO/CMO where he led the Project Management group. He began his pharmaceutical career as a process chemist at Vertex Pharmaceuticals, and then moved on to Ironwood Pharmaceuticals holding several scientific positions of increasing responsibility, leaving as a Senior Manager of Operations.